Yassanye Diana, Snead Rebecca, Proctor Kurt
Diana Yassanye, MSeD, is Co-Founder, Parasol Health Consulting, Atlanta, GA. Rebecca (Becky) Snead, BPharm, CAE, FAPhA, is Senior Director, Strategic Initiatives and Long Term Care, National Community Pharmacists Association, Alexandria, VA. Kurt Proctor, PhD, is President, NCPA Innovation Center, Alexandria, VA.
Health Secur. 2025 May-Jun;23(3):198-206. doi: 10.1089/hs.2024.0123.
The demands for vaccination, testing, and community outreach during the COVID-19 pandemic extended beyond public health capabilities. The role of independent pharmacies proved invaluable as they partnered with local, state, and federal public health entities to provide additional capacity. However, the complexities of federal partnering agreements and the limited awareness of independent pharmacy networks could delay engagement and support for underserved communities in future responses. Addressing this challenge requires tailored public-private partnership agreements and resilience frameworks for data sharing based on experience and exercises. This case study describes the experiences of independent pharmacies during the COVID-19 response, opportunities for sustained public health and pharmacy engagement, and recommendations for building a framework for rapid scale-up before the next public health emergency. Under the direction of the National Community Pharmacists Association Innovation Center, aggregators of independent pharmacies have collaborated to form the Independent Community Pharmacy Consortium for Federal Government Engagement. This consortium represents a majority of the 18,900 independent pharmacies in the United States and establishes a single initial point of contact for government agencies to reach independent pharmacies. The development and management of the consortium remains outside of the government, enabling continuity and flexibility. This case study offers a unique perspective of public health engagement and partnership with independent pharmacies based on documented responses, exercises, and discussions.
在新冠疫情期间,疫苗接种、检测及社区宣传的需求超出了公共卫生能力范围。独立药房发挥了宝贵作用,它们与地方、州和联邦公共卫生实体合作,提供了额外的能力。然而,联邦合作协议的复杂性以及对独立药房网络的认识有限,可能会在未来应对中延迟对服务不足社区的参与和支持。应对这一挑战需要根据经验和实践制定量身定制的公私合作协议以及数据共享的弹性框架。本案例研究描述了独立药房在应对新冠疫情期间的经历、持续开展公共卫生和药房合作的机会,以及为在下一次公共卫生紧急情况之前建立快速扩大规模框架的建议。在美国全国社区药剂师协会创新中心的指导下,独立药房聚合商合作成立了联邦政府参与独立社区药房联盟。该联盟代表了美国18900家独立药房中的大多数,并为政府机构与独立药房建立了单一的初始联系点。联盟的发展和管理仍由政府之外的机构负责,以确保连续性和灵活性。本案例研究基于记录的应对措施、实践和讨论,提供了公共卫生与独立药房合作的独特视角。